Very young children undergoing hematopoietic cell transplantation (HCT) are a unique and vulnerable population. We analyzed outcomes of 717 patients from 117 centers who survived relapse free for year after allogeneic myeloablative HCT for hematologic malignancy at <3 years of age, between 1987 and 2012. The median follow-up was 8.3 years (range, 1.0 to 26.4 years); median age at follow-up was 9 years (range, 2 to 29 years). Ten-year overall and relapse-free survival were 87% (95% confidence interval [CI], 85% to 90%) and 84% (95% CI, 81% to 87%). Ten-year cumulative incidence of relapse was 11% (95% CI, 9% to 13%). Of 84 deaths, relapse was the leading cause (43%). Chronic graft-versus-host-disease 1 year after HCT was associated with i...
Most pediatric patients with Hodgkin lymphoma are cured of their disease with standard combined-moda...
Importance: Allogeneic blood or marrow transplantation (BMT) is a curative option for malignant and ...
Allogeneic hematopoietic stem cell transplantation (HSCT) is a curative treatment for some hematolog...
Very young children undergoing hematopoietic cell transplantation (HCT) are a unique and vulnerable ...
We analyzed the outcomes of patients who survived disease-free for 1 year or more after a second all...
We analyzed the outcomes of patients who survived disease-free for 1 year or more after a second all...
Hematopoietic cell transplantation (HCT) is an important curative treatment for children with high-r...
AbstractWe analyzed the outcomes of patients who survived disease-free for 1 year or more after a se...
Younger children are considered to be more vulnerable to late effects (LE), which prompted us to stu...
There is marked paucity of data regarding late effects in adolescents and young adults (AYAs) who un...
AbstractRelapse of hematological malignancies after hematopoietic stem cell transplantation (HCT) is...
Hematopoietic stem cell transplantation (HSCT) has been an effective method for treating a wide rang...
We assessed late mortality in 1479 individuals who had survived 2 or more years after allogeneic hem...
Hematopoietic cell transplantation (HCT) is now a curative option for certain categories of patients...
Although HCT is an accepted component of the treatment strategy for relapsed/refractory pediatric NH...
Most pediatric patients with Hodgkin lymphoma are cured of their disease with standard combined-moda...
Importance: Allogeneic blood or marrow transplantation (BMT) is a curative option for malignant and ...
Allogeneic hematopoietic stem cell transplantation (HSCT) is a curative treatment for some hematolog...
Very young children undergoing hematopoietic cell transplantation (HCT) are a unique and vulnerable ...
We analyzed the outcomes of patients who survived disease-free for 1 year or more after a second all...
We analyzed the outcomes of patients who survived disease-free for 1 year or more after a second all...
Hematopoietic cell transplantation (HCT) is an important curative treatment for children with high-r...
AbstractWe analyzed the outcomes of patients who survived disease-free for 1 year or more after a se...
Younger children are considered to be more vulnerable to late effects (LE), which prompted us to stu...
There is marked paucity of data regarding late effects in adolescents and young adults (AYAs) who un...
AbstractRelapse of hematological malignancies after hematopoietic stem cell transplantation (HCT) is...
Hematopoietic stem cell transplantation (HSCT) has been an effective method for treating a wide rang...
We assessed late mortality in 1479 individuals who had survived 2 or more years after allogeneic hem...
Hematopoietic cell transplantation (HCT) is now a curative option for certain categories of patients...
Although HCT is an accepted component of the treatment strategy for relapsed/refractory pediatric NH...
Most pediatric patients with Hodgkin lymphoma are cured of their disease with standard combined-moda...
Importance: Allogeneic blood or marrow transplantation (BMT) is a curative option for malignant and ...
Allogeneic hematopoietic stem cell transplantation (HSCT) is a curative treatment for some hematolog...